GI Cancer Clinical Roundup

News Articles

(Yahoo! Finance) Nov 20, 2020 - Study results show diagnostic accurately detects colorectal cancer and precancerous adenomas with high sensitivity.
(ESMO Asia 2020) Nov 20, 2020 - Envafolimab (KN035), a novel PD-L1 antibody, demonstrated robust anti-tumour activity and was safe in patients with diverse advanced microsatellite instability-high/mismatch repair-deficient (MSI-H/dMMR) tumours, according to findings presented at the ESMO Asia Virtual Congress 2020.
(Yahoo! Finance) Nov 13, 2020 - New data demonstrate high accuracy of blood-based cfDNA methylation test for the detection of HCC. Test has potential to outperform current screening modalities for early stage HCC within high risk populations.
(Regenstrief [Indianapolis, IN]) Nov 10, 2020 - Regenstrief Institute and Indiana University School of Medicine research scientists have developed and tested one of the first U.S.-based models to predict personal risk for advanced precancerous polyps and colon cancer in average risk individuals.
(Northwestern Now) Oct 30, 2020 - Patients of more technically skilled surgeons, as assessed by review of operative video, have better long-term survival after surgery for the treatment of colon cancer, reports a new Northwestern Medicine study. Patients whose surgery was performed by a highly skilled surgeon had a 70 percent lower...
View all colorectal cancer news
View all liver (includes hcc, billiary tract) cancer news

Podcasts

podcastImage
Robert Figlin, MD, Steven Spielberg Family Chair in Hematology-Oncology, Cedars-Sinai Medical Center, and Geoffrey Ku, MD, Medical Oncologist, Memorial Sloan Kettering Cancer Center, discuss recent clinical developments in gastric and esophageal cancer

OBR Green

podcastImage
November 2020
Treating inoperable liver cancer has come a long way in the last 15 years from the standard treatment known as TACE. Read a summary of new clinical guidance on unresectable HCC to find out about current systemic treatment options available, learn what a working group has to say about when to use TACE, and more.

Featured Colorectal Cancer Tweets

Cathy Eng, MD
CathyEngMD - Nov 19  Just out: The impact of RAS MT on #colorectal #cancer liver resection for young vs. late onset #crc:… https://t.co/VL1DvHIjnh

Axel F. Grothey, MD
agrothey - Nov 17  @alan_burguete @OncoAlert The ones with stage 2 (or 1) disease who were overstaged by imaging studies. But those ar… https://t.co/fGKcU3h2ml

Axel F. Grothey, MD
agrothey - Nov 17  @alan_burguete @OncoAlert The ones with stage 2 (or 1) disease who were overstaged by imaging studies. But those ar… https://t.co/fGKcU3h2ml

Axel F. Grothey, MD
agrothey - Nov 17  The mRNA technology to develop vaccines in record time with high rates of immunity can be a huge breakthrough in me… https://t.co/HYSsfrecdL

Axel F. Grothey, MD
agrothey - Nov 17  The mRNA technology to develop vaccines in record time with high rates of immunity can be a huge breakthrough in me… https://t.co/HYSsfrecdL

John L. Marshall, MD
marshalj23 - Nov 14  See the best new science in gi cancers, peer review supported, funded by our growing number of survivors https://t.co/ZOHxKYkqhb